文献速递主动脉疾病

改良预装载系统用于开窗式主动脉腔内修复的早期经验

Early experience with a modified preloaded system for fenestrated endovascular aortic repair.
PubMed 文献 · J Vasc Surg · 2017-01-01

本研究前瞻性纳入欧洲三家主动脉中心2015年10月至2016年3月连续30例接受改良预装载开窗式主动脉腔内修复(FEVAR)的广泛主动脉瘤患者,报告早期临床结局与学习曲线。主要技术成功28/30(93%),辅助主要技术成功29/30(97%),主要并发症7例(23%),结论认为该改良预装载系统可安全有效用于FEVAR且学习期短。

要点

  • 改良预装载FEVAR主要技术成功率达93%,辅助主要技术成功率97%。
  • 主要并发症发生率为23%,包括2例围术期死亡。
  • 预装载引导鞘用于53/58(91%)肾动脉,术后影像未见靶血管闭塞或I/III型内漏。

核心结论

  • 基于早期经验,改良预装载系统可安全有效地用于FEVAR,技术结果良好且学习期短。
  • 该装置将治疗扩展至髂动脉入路受限的患者,但需更多患者和更长随访以确定该人群的独特风险。

研究设计与样本

  • 前瞻性、多中心早期经验研究,纳入欧洲三家高容量主动脉中心2015年10月至2016年3月连续30例接受改良预装载FEVAR的广泛主动脉瘤患者。
  • 患者中男性占80%,平均年龄70.2岁,均因非急诊指征接受定制装置修复。

主要发现

  • 修复指征包括Ia型内漏3/30(10%)、I-II-III型胸腹主动脉瘤8/30(27%)、IV型胸腹主动脉瘤或肾旁动脉瘤19/30(63%),平均瘤体直径64±13 mm。
  • 主要技术成功28/30(93%),辅助主要技术成功29/30(97%);两例技术失败分别为开放转流修复髂动脉破裂和术后数小时发现肠系膜上动脉夹层后再次支架置入。
  • 平均手术时间277±153分钟,透视时间79±36分钟,剂量面积乘积112±90 Gy cm2,对比剂用量87±46 mL。
  • 所有肾动脉开窗均成功置入支架且完成造影未见III型内漏;预装载引导鞘用于53/58(91%)肾动脉。
  • 主要并发症7例(23%),包括2例围术期死亡(卒中及髂动脉破裂导致初次转流后脓毒症);术后影像未见靶血管闭塞或I/III型内漏。

临床怎么用

  • 改良预装载系统可用于髂动脉入路受限患者的FEVAR,早期技术成功率高且学习曲线短。
  • 术中需关注髂动脉破裂和靶血管夹层等并发症,术后影像随访未见靶血管闭塞或I/III型内漏。

局限性

  • 样本量小(30例),随访时间短,需更多患者和更长随访以确定该人群的独特风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Preloaded endovascular delivery systems expand the anatomic eligibility for complex aortic repair by requiring only one iliac access vessel and providing a stable platform for guiding sheaths into challenging target vessels. This article reports the lessons learned and early clinical outcomes using a modified preloaded delivery system for fenestrated endovascular aneurysm repair (FEVAR) in three aortic centers in Europe. METHODS: From October 2015 to March 2016, consecutive patients presenting with extensive aortic aneurysm treated with a modified preloaded FEVAR were prospectively enrolled from three high volume European aortic centers. The new design is a modification of previous designs of preloaded fenestrated stent grafts and of the p-branch device platform. The technical details of implantation are described and perioperative outcomes, including the learning curve, are collected and reported. RESULTS: All patients (30 patients; 80% men; 70.2 years old) presented for nonurgent repair of either a type Ia endoleak (3/30; 10%), a type I-II-III thoracoabdominal (8/30; 27%), or a type IV thoracoabdominal or pararenal (19/30; 63.%) aneurysm repair of a mean size of 64 ± 13 mm using a custom made device. Primary technical success was achieved in 28 of 30 patients (93%) and assisted primary technical success in 29 of 30 patients (97%). The two technical failures included open conversion to repair a ruptured iliac artery and restenting of a dissected superior mesenteric artery which was recognized hours after the index procedure had finished. The mean procedure time was 277 ± 153 minutes, fluoroscopy time 79 ± 36 minutes, dose area product 112 ± 90 Gy cm2, and contrast volume 87 ± 46 mL. All renal fenestrations were successfully stented without type III endoleak on completion angiogram; the preloaded guiding sheaths were used for 53 of 58 renal arteries (91%). Challenges related to learning to the use of the modified preloaded system were experienced early and had no clinical consequences. Major complications occurred in seven cases (23%), including two perioperative deaths because of stroke and sepsis following primary conversion attributable to iliac rupture. There were no target vessel occlusions or type I/III endoleaks found on postoperative imaging. CONCLUSIONS: Based on early experience, the modified preloaded system can be safely and effectively used during FEVAR, with good technical result and a short period of learning. This device expands treatment to patients with compromised iliac access, thus, additional patients and more follow-up will be required to determine unique risks of operating in this patient population.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Maurel B, Resch T, Spear R, et al. Early experience with a modified preloaded system for fenestrated endovascular aortic repair. J Vasc Surg. 2017. PMID: 28342523. doi:10.1016/j.jvs.2016.09.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。